918
Views
23
CrossRef citations to date
0
Altmetric
Review

An update of the blockade of the renin angiotensin aldosterone system in clinical practice

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Syed Raza Shah & David E Winchester. (2018) The impact of chronic kidney disease on medication choice and pharmacologic management in patients with heart failure. Expert Review of Clinical Pharmacology 11:6, pages 571-579.
Read now
Marlies Antlanger, Sebastian Bernhofer, Johannes J. Kovarik, Chantal Kopecky, Christopher C. Kaltenecker, Oliver Domenig, Marko Poglitsch & Marcus D. Säemann. (2017) Effects of direct renin inhibition versus angiotensin II receptor blockade on angiotensin profiles in non-diabetic chronic kidney disease. Annals of Medicine 49:6, pages 525-533.
Read now

Articles from other publishers (21)

Xi Wang, Corbin A Shields, Ubong Ekperikpe, Lorena M Amaral, Jan M Williams & Denise C Cornelius. (2023) Vascular and renal mechanisms of preeclampsia. Current Opinion in Physiology 33, pages 100655.
Crossref
Jingai Fang, Chendan Wang, Jie Zheng & Yuxiang Liu. (2022) Network pharmacology study of Yishen capsules in the treatment of diabetic nephropathy. PLOS ONE 17:9, pages e0273498.
Crossref
Diego Francisco Márquez, Elena Rodríguez-Sánchez, Julián Segura de la Morena, Luis Miguel Ruilope & Gema Ruiz-Hurtado. (2022) Hypertension mediated kidney and cardiovascular damage and risk stratification: Redefining concepts. Nefrología (English Edition) 42:5, pages 519-530.
Crossref
Diego Francisco Márquez, Elena Rodríguez-Sánchez, Julián Segura de la Morena, Luis Miguel Ruilope & Gema Ruiz-Hurtado. (2022) Hypertension mediated kidney and cardiovascular damage and risk stratification: Redefining concepts. Nefrología 42:5, pages 519-530.
Crossref
Peir-Haur Hung, Yung-Chien Hsu, Tsung-Hsien Chen & Chun-Liang Lin. (2021) Recent Advances in Diabetic Kidney Diseases: From Kidney Injury to Kidney Fibrosis. International Journal of Molecular Sciences 22:21, pages 11857.
Crossref
Johannes J. Kovarik, Christopher C. Kaltenecker, Oliver Domenig, Marlies Antlanger, Marko Poglitsch, Chantal Kopecky & Marcus D. Säemann. (2021) Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study. Diabetes Therapy 12:9, pages 2485-2498.
Crossref
Akihiro Kuma, Xiaonan H. Wang, Janet D. Klein, Lin Tan, Nawazish Naqvi, Fitra Rianto, Ying Huang, Manshu Yu & Jeff M. Sands. (2020) Inhibition of urea transporter ameliorates uremic cardiomyopathy in chronic kidney disease. The FASEB Journal 34:6, pages 8296-8309.
Crossref
Thomas Datzmann, Susanne Fuchs, Daniel Andree, Bernd Hohenstein, Jochen Schmitt & Christoph Schindler. (2019) Systematic review and meta-analysis of randomised controlled clinical trial evidence refutes relationship between pharmacotherapy with angiotensin-receptor blockers and an increased risk of cancer. European Journal of Internal Medicine 64, pages 1-9.
Crossref
Xiaoliang Wang & Joseph I. Shapiro. (2019) Evolving concepts in the pathogenesis of uraemic cardiomyopathy. Nature Reviews Nephrology 15:3, pages 159-175.
Crossref
Diego Francisco Márquez, Gema Ruiz-Hurtado, Julian Segura & Luis Ruilope. (2019) Microalbuminuria and cardiorenal risk: old and new evidence in different populations. F1000Research 8, pages 1659.
Crossref
Ying-Ying Zhang, Ying Yu & Chen Yu. 2019. Renal Fibrosis: Mechanisms and Therapies. Renal Fibrosis: Mechanisms and Therapies 671 691 .
Feng Liu & Shougang Zhuang. 2019. Renal Fibrosis: Mechanisms and Therapies. Renal Fibrosis: Mechanisms and Therapies 625 659 .
An-Fang Huang, Hui Li, Lei Ke, Chao Yang, Xiao-Yan Liu, Zu-Cheng Yang, Fen Xu, Hong Jia & Wang-Dong Xu. (2018) Association of angiotensin-converting enzyme insertion/deletion polymorphism with susceptibility to systemic lupus erythematosus: a meta-analysis. International Journal of Rheumatic Diseases 21:2, pages 447-457.
Crossref
Emilia D'Elia, Attilio Iacovoni, Muthiah Vaduganathan, Ferdinando L. Lorini, Stefano Perlini & Michele Senni. (2017) Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides. European Journal of Heart Failure 19:6, pages 710-717.
Crossref
Gema Ruiz-Hurtado & Luis M Ruilope. (2017) Sacubitril/valsartan in the treatment of arterial hypertension: an unaccomplished promise?. Hypertension Research 40:5, pages 439-440.
Crossref
Diego F Marquez, Gema Ruiz-Hurtado & Luis Ruilope. (2017) The impact of antihypertensives on kidney disease. F1000Research 6, pages 611.
Crossref
Martina Monti, Erika Terzuoli, Marina Ziche & Lucia Morbidelli. (2016) H2S dependent and independent anti-inflammatory activity of zofenoprilat in cells of the vascular wall. Pharmacological Research 113, pages 426-437.
Crossref
Gema Ruiz-Hurtado, Pantelis Sarafidis, María S. Fernández-Alfonso, Bernard Waeber & Luis M. Ruilope. (2016) Global cardiovascular protection in chronic kidney disease. Nature Reviews Cardiology 13:10, pages 603-608.
Crossref
Matthew D. Breyer & Katalin Susztak. (2016) The next generation of therapeutics for chronic kidney disease. Nature Reviews Drug Discovery 15:8, pages 568-588.
Crossref
Anjay Rastogi, Farid Arman & Setareh Alipourfetrati. (2016) New Agents in Treatment of Hyperkalemia: an Opportunity to Optimize Use of RAAS Inhibitors for Blood Pressure Control and Organ Protection in Patients with Chronic Kidney Disease. Current Hypertension Reports 18:7.
Crossref
Astgik PetrosyanIlenia ZanussoMaria Lavarreda-PearceScott LeslieSargis SedrakyanRoger E. De FilippoGiuseppe OrlandoStefano Da SaccoLaura Perin. (2016) Decellularized Renal Matrix and Regenerative Medicine of the Kidney: A Different Point of View. Tissue Engineering Part B: Reviews 22:3, pages 183-192.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.